Stressed oligodendrocytes (OLGs) activate microglia to produce an inflammatory response, and the impairment of mitochondria further aggravates OLG damage, which is the earliest pathological change in multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. Matrine (MAT), a tetracyclic quinolizine alkaloid derived from the herb radix sophorae flavescentis, has been shown to effectively ameliorate clinical signs of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. However, the mechanisms underlying the effect of MAT treatment need to be further studied. In the present study, we show that MAT effectively suppressed ongoing EAE, and significantly reduced the expression of caspase-3 and alpha Bcrystallin in OLGs, therefore lessen OLG apoptosis, microglial activation and inflammatory factors secretion. MAT treatment also reduced the content of cytochrome c and malondialdehyde, an oxidative stress marker, in the central nervous system. In contrast, the levels of autophagy-related proteins Beclin1, microtubule-associated protein l light chain 3 and glutathione peroxidase was upregulated, hence enhancing mitochondrial autophagy and alleviating the imbalance of the oxidation/antioxidation system caused by mitochondrial damage. Our research indicates that MAT is effective in treating EAE, at least in part, by protecting OLGs through inhibiting their apoptosis and enhancing mitochondrial autophagy.
Introduction
Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are chronic inflammatory demyelinating diseases of the central nervous system (CNS), characterized by myelin destruction, glial activation, and neurological disability (Hendrickx et al., 2017; Silva et al., 2018) . It is believed that the major mechanism underlying disease progression of MS/EAE is oligodendrocyte (OLG) death by apoptosis, axonal loss and myelin destruction (Kan et al., 2017) . In the CNS, infiltrating Th1/Th17 cells produce proinflammatory cytokines, which activate microglia and induce them into a type 1 (M1) phenotype. These cells play an important role in the pathogenesis of MS/EAE (Huhner et al., 2017) . On the other hand, certain anti-inflammatory mechanisms are also activated to protect CNS tissues from further damage. For example, the small heat-shock protein alpha B-crystallin (HSPB5) selectively accumulates in stressed OLGs, where it exerts broad neuroprotective and anti-inflammatory effects (Ummenthum et al., 2016; van Noort et al., 2010) . HSPB5 can also act as an endogenous Toll-like receptor (TLR) 2 agonist, thus activating an innate regulatory response of microglia (Peferoen et al., 2015) .
Mitochondria are subcellular centers of energy metabolisms and crucial regulators of cell survival and death (Kalman et al., 2007) , and their dysfunction, which is most severe within inflammatory foci (Desai and Smith, 2017) , is thought to play a significant role in the OLG loss in MS (Veto et al., 2010; Lassmann and van Horssen, 2011) . For another, autophagy, as a lysosome-dependent degradation pathway, can remove damaged cellular organelles and proteins, thus contributing to maintaining cellular homeostasis (Liang and Le, 2015) . Autophagy is the major means of selectively removing damaged or undesirable mitochondria to ensure their quality, a process known as mitochondrial autophagy or mitophagy (Tran et al., 2018) . However, the reduced concentration of Beclin1, an important autophagy-associated protein in inflammatory lesions is one of the significant factors involved in the pathogenesis of MS and EAE (Shao et al., 2017; Salminen et al., 2013) . Therefore, approaches that inhibit CNS inflammation and enhance mitochondrial autophagy may be effective for neural protection and repair.
Matrine (MAT), a natural alkaloid component extracted from the herb radix sophorae flavescentis, has been widely used in the treatment of human hepatitis B and leukopenia, with few adverse reactions (Wang et al., 2017) . Our previous studies showed that MAT reduced inflammatory responses in both the CNS and periphery and ameliorated neurological functioning in EAE (Kan et al., 2017; Zhang et al., 2017) . Further, MAT also protected neurons from damage by focal cerebral ischemia (Xu et al., 2012) . However, whether MAT can suppress apoptosis and induce mitochondrial autophagy to protect OLGs in EAE has not been studied. The present study focuses on this important question, and further addresses the mechanism underlying MAT action. We discovered that MAT has therapeutic effect in ongoing EAE through reducing OLG apoptosis, thereby inhibiting microglial activation and inflammatory factor secretion. Our data demonstrate that, for the first time, MAT protects OLGs from apoptosis through enhancing mitochondrial autophagy.
Materials and methods

Animals and EAE induction
Female Wistar rats, 6-8 weeks old (180-200 g), were purchased from the Beijing Vital River Experimental Animal Company, China, and housed in specific pathogen-free conditions at the Henan Province Chinese Medicine Research Institute, China. EAE was induced as described previously (Khezri et al., 2018) . Briefly, spinal cord homogenate of guinea pigs (Beijing Vital River Experimental Animal Company) was emulsified with the same volume of complete Freund's adjuvant (Sigma, St. Louis, MO, USA) containing 6 mg/mL Bacillus Calmette--Guérin vaccine (Solarbio Bio-Technology Co., Shanghai, China). Each rat was subcutaneously injected at four separate sites with 0.5 mL of antigen emulsion.
Ethics approval and consent to participate
The animal experimental protocol was reviewed and approved by the Institutional Animal Care and Use Committee of Zhengzhou University. Animals were treated according to protocols established by the Ethics Committee of Zhengzhou University; the in vivo experiments were carried out in accordance with the approved guidelines and approved by the Ethics Committee of Zhengzhou University, ethical review number: 2019-KY-142.
MAT treatment, clinical scoring, and weight
Immunized rats were randomly divided into three groups (n = 10 each group): (1) MAT (Tianqing Phar. Co., Chiatai, Jiangsu, China) was dissolved in normal saline and injected intraperitoneally (i.p.) at 250 mg/kg daily, starting from day 11 post immunization (p.i.); (2) immunized rats that received vehicle i.p. served as control; (3) nonimmunized naïve rats that received vehicle i.p. served as the naïve control. The rats were monitored and weighed daily by two independent observers to evaluate EAE clinical scores. Neurological signs were assessed as follows: 0 = no clinical score, 1 = loss of tail tone, 2 = hind limb weakness, 3 = hind limb paralysis, 4 = forelimb paralysis, and 5 = moribund or death.
Histopathological evaluation
On day 18 p.i., the rats were sacrificed and the spinal cords and brains were harvested after extensive perfusion with saline. The lumbar enlargement of the spinal cords and a piece of brain tissues were collected, embedded in paraffin, and processed for histological evaluation. Inflammatory infiltration was determined by hematoxylin and eosin (H &E) staining and demyelination by Luxol fast blue (LFB) staining. Histopathological examination was performed and scored in a blinded fashion as follows: for inflammation: 0, no inflammatory cells; 1, a few scattered inflammatory cells; 2, organization of inflammatory infiltrates around blood vessels; and 3, extensive perivascular cuffing with extension into parenchyma and for demyelination: 0, none; 1, rare foci; 2, a few areas of demyelination; and 3, large (confluent) areas of demyelination. Scores of demyelination and inflammation were calculated by Image-Pro Plus 6.0 (IPP6.0) software. For each animal, three histological sections were analyzed and their average scores were calculated.
TUNEL assay
To quantify apoptosis of OLGs, T24 xenograft sections were processed for in situ immunocytochemical localization of nuclei exhibiting DNA fragmentation using the technique of terminal deoxynucleotidyl transferase-(TdT-) mediated dUTP digoxigenin nick-end labeling (TUNEL) in conjunction with an apoptosis detection kit (In Situ Cell Death Detection Kit, POD). The protocols were followed according to the manufacturer's instructions.
Paraffin-embedded samples (3 μm thick sections) were deparaffinized and rehydrated with xylene and ethanol and permeabilized with 20 μg/mL of proteinase K for 30 min. Endogenous peroxidase was inactivated by coating the samples with 3% H 2 O 2 . Sections were rinsed with PBS and then immersed for 60 min in TdT buffer at 37°C and then incubated for 30 min with antidigoxigenin peroxidase conjugate, followed by peroxidase substrate (3'-diaminobenzidine tetrahydrochloride [DAB] ). Finally, sections were counterstained with 0.5% (wt/vol) methyl green. For each group, ten sections were examined in a blinded fashion. Image-Pro Plus 6.0 software was used to calculate the quantification of target protein expression.
Immunofluorescence double labeling
Lumbar spinal cords and brains were immediately harvested after extensive perfusion on day 18 p.i. and fixed in 4% paraformaldehyde; serial cryostat longitudinal sections were cut at 5 μm thickness for immunofluorescence analysis. Briefly, non-specific binding was blocked with 3% bovine serum albumin (BSA) (Serotec, UK), and permeabilized with 0.3% Triton X-100 in 1% BSA-PBS for 30 min. The sections were then incubated in blocking solution at 4°C overnight with primary antibodies specific for rabbit anti-Beclin1 (IgG; Abcam, Cambridge, UK), rabbit anti-TOMM20 (IgG; Abcam, Cambridge, UK), rabbit anti-LC3A/B (IgG; Bioss, Beijing, China), rabbit anti-cytochrome c (Cyt c) and mouse anti-olig2 (both IgG; Proteintech, Wuhan, China) and then incubated with secondary antibodies rabbit anti-Cy 3 and mouse anti-FITC (both IgG; Proteintech, Wuhan, China) at room temperature (RT) for 2 h and mounted with 4',6-diamidino-2-phenylindole (DAPI, Roche, Basel, Switzerland), then washed with PBS, coverslipped, and examined under a fluorescence microscope (Leica Microsystem AG, Switzerland). As a negative control, additional sections were treated similarly, but the primary antibodies were omitted. All pictures were captured by confocal microscope (Olympus Fluoview FV1000). For each group, ten sections were examined in a blinded fashion. Image-Pro Plus 6.0 software was used to calculate the quantification of target protein expression.
Western blot
Brain and spinal cord were homogenized on ice in a glass homogenizer in ice-cold lysis buffer (1× PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS, RIPA) supplemented with protease inhibitors. Lysates were centrifuged at 14,000 × g for 5 min at 4°C, and the supernatants were collected. Protein concentrations were determined by a Bradford protein assay. Equal amounts of protein were separated by SDS-PAGE and transferred onto a polyvinylidene fluoride filter (PVDF) membrane. Membranes were blocked with 5% non-fat milk and incubated at 4°C overnight with rabbit anti-IL-1β, rabbit anti-HSPB5, and rabbit anti-Cas-3 (all 1:1000, Abcam). Bands were visualized by HRP-conjugated secondary antibodies (1:4000, Zymed Laboratories, USA) and chemiluminescence (ECL) kit under ECL system (Beijing Zhongshan Biotech Co, Beijing, China). For each group, ten sections were examined in a blinded fashion. BandScan 5.0 software was used to calculate the relative quantification of target protein expression.
Colorimetry
On day 18 p.i., brain and spinal cord were harvested after extensive perfusion with normal saline and then homogenized. Supernatants were assayed by colorimetry for detection of expression of MDA and glutathione peroxidase (GSH-Px) following the instructions of MDA reagent kit and GSH-Px reagent kit (Nanjing Jiancheng Institute of Biological Engineering, Nanjing, China).
Statistical analyses
All data are presented as mean ± SD. Statistical analyses were performed with SPSS 16.0 (SPSS, Chicago, USA). Multiple comparisons were performed using the Kruskal-Wallis test, or ANOVA, followed by the LSD-t test, as appropriate. A P value less than 0.05 was considered significant.
Results
MAT alleviates the clinical severity of ongoing EAE
To determine the effect of MAT in OLG protection, we induced EAE in Wistar rats, and treated them at disease onset. As shown in Fig. 1A , when MAT was administered from day 11 p.i., the severity of EAE was significantly reduced when compared with the saline-treated rats, and the average weight loss was also reduced (Fig. 1B) . To verify the correlation between the clinical signs of EAE and CNS inflammation, intumescentia lumbalis of the spinal cord in all groups were examined by HE staining. Inflammatory infiltrates were widely distributed in the white matter of the spinal cord of vehicle-treated EAE rats, and this infiltration was markedly inhibited by MAT treatment (Fig. 1C upper panel, and Fig. 1D ). Moreover, MAT treatment dramatically decreased CNS demyelination compared to vehicle-treated control rats (Fig. 1C , lower panel, and Fig. 1E ).
MAT protects OLGs from apoptosis
To determine the effect of MAT treatment in protecting OLGs, thus reducing demyelination, we tested the numbers of cells co-localized TUNEL (apoptotic) with OLIG2 (OLGs) via immunofluorescence double staining. As shown in Fig. 2A , only a few TUNEL + cells were observed in hippocampal fimbria of the brain, while there were a large number of these cells in vehicle-treated control EAE mice, which were colocalized with OLIG2. In contrast, the number of TUNEL + OLG apoptotic was significantly reduced after MAT treatment (Fig. 2B) . These results suggest that MAT can protect OLGs from CNS inflammation-induced apoptosis.
MAT inhibits microglia activation and IL-1β production by decreasing caspase-3 expression
Increased expression of caspase-3 is the critical event during the progress of intrinsic apoptosis (Ahmed et al., 2002) . HSPB5 is the most abundant transcript in early active MS lesions, where it selectively accumulates in stressed OLGs and can activate microglia (Ummenthum et al., 2016; van Noort et al., 2010) . Overactivated microglia secrete inflammatory cytokines, such as TNF-α, IL-1β and IL-18, which play an important role in CNS tissue damage in MS/EAE. Among them, IL-1β can drive Th0 cell differentiation into Th17 cells, release IL-17A, GM-CSF, etc., which are essential in the pathogenesis of EAE (Shao et al., 2017; Sloka et al., 2013) . We then evaluated the expression of caspase-3, HSPB5 and IL-1β in brain and spinal cord using Western blot (Fig. 3A, B) . Our results show that the expression of caspase-3, HSPB5 and IL-1β markedly elevated in the vehicle-treated EAE rats compared to naïve rats, whereas their expression was significantly decreased after MAT treatment (Fig. 3C, D) .
MAT inhibits Cyt c protein expression in OLGs
The translocation of Cyt c from mitochondria to the cytoplasm is a critical step in cellular apoptosis (Jemmerson et al., 2005) . We thus determined Cyt c expression in OLGs in hippocampal fimbria of the brain by immunofluorescence double staining (Al Rahim et al., 2013) (Fig. 4A ). We found that the Cyt c expression was much greater in vehicle-treated EAE rats than in naïve rats, while MAT treatment significantly reduced this expression compared to the vehicle-treated EAE group (Fig. 4B) .
MAT enhances mitochondrial autophagy
The function of mitochondrial autophagy is impaired in EAE brain OLGs, and the Beclin1 complex and LC3 plays a major role in the process (Shao et al., 2017; Salminen et al., 2013) . We thus determined Beclin1 expression in OLGs in hippocampal fimbria of the brain by immunofluorescence double staining (Fig. 5A ). We found that Beclin1 expression was decreased in the CNS of vehicle-treated EAE rats compared with naïve rats, while its expression was significantly enhanced after MAT treatment (Fig. 5C ). Autophagy, as manifested by LC3 expression, in mitochondria (marked by TOMM20) was further explored by immunofluorescence double staining (Fig. 5B) . Statistical analysis showed a significant reduction of LC3 expression in MAT-treated rats compared to control rats (Fig. 5D) , with a similar trend as that for beclin1.
MAT inhibits the release of ROS from the CNS of EAE rats
It was found that the ability of neurons to guard against oxidative stress was weakened during mitochondrial dysfunction, allowing endogenous ROS to be released from mitochondria, which, in turn, can intensify oxidative stress. We thus identified MDA, an oxidative stress marker, and GSH-Px, an antioxidant enzyme, in brain and spinal cord using the colorimetric method. The results indicated that MDA content was visibly increased in vehicle-treated EAE rats compared to naïve rats, and that MAT treatment reduced MDA content compared to the vehicle-treated EAE group (Fig. 6A) . In contrast, GSH-Px activity in these groups was the opposite of MDA (Fig. 6B ).
Discussion
OLGs are myelin sheath-forming cells in the CNS, and their loss and dysfunction lead to demyelination, a major cause of irreversible damage in patients with MS (Giovannoni, 2018; Peferoen et al., 2014) . In MS and EAE, CNS autoimmune inflammation causes OLG apoptosis and death, resulting in demyelination and axonal damage (Giovannoni, 2018) . Our previous studies showed that MAT exerts therapeutic effects on EAE through regulation of immune responses, induction of neurotrophic factors by CNS cells, and protection of the blood-brain barrier (Kan et al., 2017; Zhang et al., 2017; Liu et al., 2017) ; however, the mechanism of action of this natural alkaloid in neural protection is still unknown. Here, we demonstrate that MAT inhibits the expression of caspase-3 and HSPB5 in OLGs, thus protecting them from apoptosis. MAT also reduced the content of Cyt c and MDA in the CNS, but increased the expression of Beclin1, LC3 and GSH-PX, hence enhancing mitochondrial autophagy to maintain cell homeostasis.
HSPB5, a member of the small Hsp family closely related to Hsp27, is constitutively expressed in OLGs, whereas its expression is found in other glial cells in MS and brain ischemia (Klopstein et al., 2012) . The immune regulatory profile of HSPB5-activated microglia, as well as animal model data, suggest a neuroprotective effect of the HSPB5-induced inherent reaction (Holtman et al., 2017) . Recruited by the innate response, however, such T cells, reacting to the accumulation of HSPB5 by an adaptive immune response, can release IFN-γ and change the protective response of microglia and macrophages to HSPB5 into a robust pro-inflammatory classic response (Bsibsi et al., 2014; van Noort et al., 2012) . On the other hand, activated microglia, through secreting inflammatory mediators, play an important role in the pathogenesis of neurodegenerative diseases such as Parkinson's disease, MS and Alzheimer's disease (Haas et al., 2016; Pajohanfar et al., 2017; Bai et al., 2018) . Among these mediators, IL-1β is pivotal in the neuroinflammatory response that drives Th17 differentiation and promotes leukocyte infiltration by eliciting the expression of a large number of cytokines, chemokines, and adhesion molecules (Jha et al., 2010) . Our results show that MAT can reduce the expression of HSPB5, consequently decreasing microglia activation and reducing the pro-inflammatory response of the CNS, eventually protected OLGs from apoptosis.
Mitochondria play a decisive role in cellular homeostasis in energy and redox states (Singh et al., 2018) . The dysfunction or loss of Fig. 3. MAT reduced caspase-3, HSPB5 and IL-1β levels. Brains and spinal cords were harvested from naïve rats, MAT-and vehicletreated EAE rats. The expression of caspase-3, HSPB5, IL-1β was determined in brain (A) and spinal cord (B) by Western blot. (C), (D) Western blots analysis showed that the levels of caspase-3, HSPB5 and IL-1β were significantly increased in the brain and spinal cord of control mice with EAE at day 17 p.i. compared to naïve control mice. Moreover, the levels of caspase-3, HSPB5 and IL-1β were significantly decreased in the brain and spinal cord of MAT treated rats with EAE at day 17 p.i. compared to control mice with EAE. Symbols represent mean ± SD; n = 10 rats per group. ***p < 0.001, comparison between naïve and vehicle-treated EAE groups. #p < 0.05, ##p < 0.01, ###p < 0.001, comparison between vehicle-and MAT-treated EAE groups. mitochondria could intrinsically be linked to the deterioration of OLGs/ myelin and neurons/axons (Yamamoto et al., 2017) . Pathologic opening of the permeability transition pore (PTP), a high-conductance inner membrane channel, is a crucial event in mitochondrial dysfunction, which causes inner membrane permeability to cytosol (Su et al., 2012) . During apoptosis, the abnormal structure and function of mitochondria lead to swelling of the organelles, with the subsequent release of apoptogenic factors, including Cyt c, Smac/DIABLO, AIF, and Omi/HtrA2 into the cytosol. These factors activate a cascade of proteases, which take charge of nuclear DNA fragmentation and cell death (Savino et al., 2013) . Among these factors, we have shown that OLGs of control EAE rats had increased expression of Cyt c, a key protein in mitochondrial apoptosis, which can lead to irreversible damage to mitochondrial respiration. Its release from mitochondria to cytoplasm would trigger the formation of apoptotic bodies and the activation of caspase-9 (Jemmerson et al., 2005) . Our finding that MAT treatment significantly inhibited Cyt c protein level in the mitochondria of OLGs, thereby reducing release to the cytoplasm, provides a mechanism underlying the protective capacity of MAT treatment for OLGs.
Autophagy is a basic pathway to maintain cellular homeostasis via degrading damaged organelles and proteins, such as endoplasmic reticulum, mitochondria and peroxisomes, and recycling necessary molecules like amino acids and fatty acids to ensure cellular survival during stress conditions (Moloudizargari et al., 2017) . Keller et al. reported that the complex functions of autophagy-related (Atg) proteins, such as Atg5, Atg7, LC3, p62, Beclin1, AMPK and mTOR, have a vital role in the development and procession of MS, and the stabilization of mitochondrial function has a profound effect on the regeneration and protection of OLGs and demyelinated axons (Keller and Lunemann, 2017) . It was also found that mitochondrial autophagy or mitophagy is the main way of controlling mitochondrial quality, and it specifically targets damaged and cytotoxic mitochondria (Sun et al., 2018) . As a well-known regulation pathway in mitophagy, Beclin1, one of the first autophagy proteins to be identified in mammals, is a core part of the Class III phosphatidylinositol-3-kinase (PI3K) complex, which is indispensable for the formation of autophagosomes (Zhen et al., 2015) . In addition, Beclin1 has a conserved BH3 domain, which can combine with the anti-apoptotic family members Bcl-2 and Bcl-XL (Kanno et al., 2009) . Hence, Beclin1 is a bridge between autophagy and apoptosis. Meanwhile, in most studies, LC3 (the primary Atg8 homolog detected in mammalian cells) is typically referred to as the autophagosome marker in itself (Martinez-Arroyo et al., 2019) . Given the special importance of Cyt c, Beclin1 and LC3 in the regulation of mitochondrial apoptosis, in the present study we defined the influence of MAT on their expression, i.e., that MAT can reverse the tendency toward largely increased Cyt c expression in OLGs and decreased Beclin1 and LC3 expression in mitochondria during EAE. These results are consistent with the extent of OLG apoptosis and disease severity, and indicate that MAT treatment can protect OLGs by inhibiting mitochondrial apoptosis and promoting mitochondrial autophagy.
ROS is one of the byproducts of normal cell metabolism, in which electron leakage of mitochondrial complexes is the prime builder of ROS. As a group of highly reactive radicals, ROS contributes to vulnerable cellular structures (Moloudizargari et al., 2017) . To prevent damage by ROS, cells have effective antioxidative enzyme systems, including superoxide dismutase, catalase and GSH-Px (Ciftci et al., 2015) ; defects in antioxidant systems and abundant ROS production, which collapses the endogenous antioxidant capacity, result in oxidative stress (Mossakowski et al., 2015) . In addition to inflammation via activated microglia causing excessive ROS formation, mitochondrial Brains and spinal cords were harvested from naïve rats, MAT-treated and vehicle-treated EAE rats. (A) Immunofluorescence double staining indicated that OLGs marker OLIG2 (green) was colocalized with Beclin1 (red) in the hippocampal fimbria of the brain of EAE rats. (B) Immunofluorescence double staining indicated that LC3 (green) was colocalized with TOMM20 (red) in the hippocampal fimbria of the brain of EAE rats. (C) and (D) Quantitative analysis of numbers of Beclin1 and LC3 positive cells. Symbols represent mean ± SD; n = 10 rats per group. ***p < 0.001, comparison between naïve and vehicletreated EAE groups. ###p < 0.001, comparison between vehicle-and MATtreated EAE groups. dysfunction impairs the ability of neurons to resist oxidative stress and allows the release of endogenous ROS produced by the mitochondria (Dumont and Beal, 2011) . During EAE, mitochondria are specifically sensitive to the disruptive effects of oxidative compounds and furthermore can aggravate oxidative stress and facilitate cell death and axonal loss (Tully and Shi, 2013) . This interaction results in oxidation-antioxidation system imbalance, leading to a substantial consumption of antioxidant enzymes such as GSH-Px and a large accumulation of MDA, an oxidative stress marker (Ye et al., 2014; He et al., 2014) . Thus, due to the capacity of MAT to inhibit oxidative stress and reduce the consumption of antioxidant enzymes in OLGs, treatment with this reagent can enhance the tolerance of mitochondria to oxidative compounds and maintain the balance between oxidation and antioxidation, thus protecting OLGs from CNS inflammation-induced cell death.
Conclusions
In conclusion, our study demonstrates that MAT effectively inhibits ongoing EAE and protects OLGs, which can most likely be ascribed to two central mechanisms. First, MAT reduces the expression of caspase-3 and HSPB5 in stressed OLGs to inhibit OLG apoptosis, microglial activation and inflammatory factor secretion. Second, MAT enhances mitochondrial autophagy, and alleviates the imbalance of the oxidation/ antioxidation system caused by mitochondrial damage and microglial activation, by inhibiting the expression of Cyt c and MDA, and enhancing the expression of Beclin1, LC3 and GSH-PX. These mechanisms, together, underlie the effect of MAT in preserving OLGs from apoptosis during CNS autoimmunity. While in the present study we focus on the Cyt c induced apoptosis pathway, we are aware that other important factors, for example, glutamate excitotoxicity, is one of the main causes to stimulate (AIF) release from mitochondria in neurons, thus inducing their apoptosis (Yang et al., 2014; Kim et al., 2018) . Whether these pathways are also a mechanism for OLG death and whether MAT treatment impacts these apoptosis pathways to protect OLGs will be investigated in the near future. Fig. 6 . MAT inhibited the release of ROS, but enhanced that of GSH-Px, from the CNS of EAE rats. Brains and spinal cords of naïve rats, MAT-treated and vehicle-treated EAE rats were harvested, homogenized, and supernatants were assayed by colorimetry for concentrations of MDA (A) and the activities of GSH-Px (B). Symbols represent mean ± SD; n = 10 rats per group. ***p < 0.001, comparison between naïve and vehicle-treated EAE groups. ###p < 0.001, comparison between vehicle-and MAT-treated EAE groups.
